Private equity in cardiology raises overuse concerns
As private equity’s infiltration into cardiology expands, what does this mean for the cost and quality of care? More
As private equity’s infiltration into cardiology expands, what does this mean for the cost and quality of care? More
At the Lown Institute event on hospital racial inclusivity, health equity experts weighed in on hospital segregation and strategies for improving inclusivity. Watch the full event recording! More
Most hospitals say advancing health equity in their communities is a priority, and our latest report examines just how well they’re doing. More
CMS just announced AHEAD, a new model of care for states that provides an alternative to traditional fee-for-service payment. What does this model entail and how will it impact hospitals? More
The list of ten drugs for Medicare price negotiation has been published! What do we know about these Medicare "blockbusters"? And how are drugmakers taking the news? More
Arnold Ventures (AV) has recently supported the Lown Institute with grant funding for two projects, allowing the organization to significantly expand its research into the financial behavior of U.S. hospitals. More
Register now for our Racial Inclusivity launch on Sept. 19, 2023. More
Cancer screenings save lives, right? It's actually more complicated than that... More
As health equity has become a central focus for hospitals and other healthcare institutions, how could AI help – or hinder – these efforts? More
The clear connection between social factors and health has led to the adoption of health-related social needs screening in an attempt to address health concerns outside of clinic walls. How can we make sure these screeners and resulting referral services are effective? More
If you want to see an epic battle between hospitals and pharma, look no further than the 340B drug discount program. Why is this program so controversial, and what do new studies show about its effectiveness? More
Unlike its predecessor drug aducanumab, lecanemab actually showed a statistically significant difference in slowing cognitive decline in its clinical trial. But can the drug improve patients’ quality of life? More
Noelle Serino, the Lown Institute's newest policy analyst, traces her commitment to public health back to one life-changing event... More
Hospitals are an outlier among nonprofits when it comes to CEO pay, and hospitals in Los Angeles are no exception. Here's what one union is doing about it... More
Critical Access hospitals serve patients that would otherwise have limited access to healthcare. How do they perform on the Lown Index? Let's take a look... More